OPW
TEVA icon

Oxler Private Wealth’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Oxler Private Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-700
Closed -$5.65K – 304
2022
Q3 		$5.65K Hold
700
– – ﹤0.01% 397
2022
Q2 		$5.26K Buy
+700
New +$6.1K ﹤0.01% 226
2021
Q1 		– Sell
-1,000
Closed -$9K – 203
2020
Q4 		$9K Buy
+1,000
New +$9.58K 0.01% 211

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Oxler Private Wealth's TEVA Position: Q4 2022 in Review

Oxler Private Wealth sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2022, closing a stake of 700 shares — an estimated $5.65K sold.

Oxler Private Wealth first reported a position in TEVA in Q4 2020 and held it in 3 quarters. The position peaked at $9K in Q4 2020. 421 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Oxler Private Wealth reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2022 after selling out during the quarter.
  • Oxler Private Wealth sold 700 Teva Pharmaceutical Industries Limited shares in Q4 2022, an estimated $5.65K.
  • Oxler Private Wealth first reported a position in Teva Pharmaceutical Industries Limited in Q4 2020 and held it in 3 quarters.
  • Oxler Private Wealth's Teva Pharmaceutical Industries Limited position peaked at $9K in Q4 2020.
  • 421 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2022.

Based on Oxler Private Wealth's 13F filing for Q4 2022, filed 13 Feb 2023.